DiscernDx
DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.
1 past transactions
Applied Proteomics
Acquisition in 2018
Applied Proteomics, Inc., founded in 2006 and headquartered in San Diego, California, specializes in developing noninvasive and blood-based tests for monitoring and early detection of disease. The company focuses on protein biomarkers, offering a proteomics platform that enables the discovery and application of these biomarkers in diagnostics and personalized medicine to enhance healthcare outcomes. One of their key products is the SimpliPro Colon test, which provides diagnostic solutions based on protein interactions within the body.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.